Actively Recruiting
Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy
Led by Haukeland University Hospital · Updated on 2023-09-26
600
Participants Needed
2
Research Sites
820 weeks
Total Duration
On this page
Sponsors
H
Haukeland University Hospital
Lead Sponsor
H
Helse Stavanger HF
Collaborating Sponsor
AI-Summary
What this Trial Is About
The overall aim of the current project is to assess the acute and long term outcome of ECT (both patient and clinician rated) in a non-selected patient cohort from ordinary clinical activity, and to seek out factors predicting response and remission, side effects and relapse.
CONDITIONS
Official Title
Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients treated with ECT for major depression (F31.3-5, F32, F33) at Haukeland University Hospital or Stavanger University Hospital after 2013
- Written consent to enrolment into the Regional Register for neurostimulation
You will not qualify if you...
- ECT performed on other indications than major depression
- No consent to the register
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Haukeland University Hospital
Bergen, Norway, 5021
Actively Recruiting
2
Stavanger University Hospital
Stavanger, Norway
Actively Recruiting
Research Team
U
Ute Kessler, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here